Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Angel Yeast Partners with BakeMark Launching Multiple Product Lines at Bakery China 2024 2024-06-04 19:00
MicroAlgo Inc. (NASDAQ: MLGO) Announced to Jointly Establish a Micro-Consciousness Quantum Research Center With WIMI (NASDAQ: WIMI) 2024-06-04 16:10
AmpleLogic Launches Advanced aPaaS for Life Sciences with 14 Ready-to-Use Applications 2024-06-04 13:30
GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings 2024-06-04 13:00
Fapon Biopharma Announces a Safer Immunotherapy for Cancers 2024-06-04 09:42
RemeGen Reports Proof-of-Concept Phase I/II Clinical Study Results for Self-Developed, Potential First-in-Class Antibody-Drug Conjugate RC88 2024-06-04 09:38
Built by Nature Prize Awards €500,000 to Biobased Construction Innovators 2024-06-04 08:00
BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx 2024-06-03 23:37
Datasea Agreement already provided $2.8 million Information Service for its Highly Specialized 5G-AI Communications Platform 2024-06-03 22:00
Minghui Pharmaceutical Presents Phase 1/2 Clinical Data of MHB088C (B7-H3 ADC) as Monotherapy for the Treatment of Patients with Recurrent or Metastatic Solid Tumors at the 2024 ASCO Annual Meeting 2024-06-03 21:30
Visionary Pioneering Innovation Across Four Key Frontiers 2024-06-03 20:30
Waters Becomes First Liquid Chromatography Column Provider to Receive My Green Lab ACT Ecolabel Certification 2024-06-03 20:00
HistoIndex to Showcase Groundbreaking AI-powered Stain-free Digital Pathology Advances with 8 Accepted Abstracts at EASL Congress 2024 2024-06-03 20:00
Formosa Laboratories Completes the Acquisition of Synchem to Expand North American CDMO Footprint 2024-06-03 13:01
MGI Tech's DNBSEQ-E25 and G99 Platforms Set Record for Sequencing Applications on Mount Everest 2024-06-03 11:35
Leads Biolabs' Innovative Cancer Treatment LBL-024, an Anti-PDL1/4-1BB Bispecific Antibody Achieved Outstanding Phase II Results, Has Been Presented in Clinical Science Symposium at 2024 ASCO Annual Meeting. 2024-06-03 10:57
Alphamab Oncology Presented Chinese Clinical Data of Anti-HER2 Bispecific ADC JSKN003 for the First Time at the 2024 ASCO Annual Meeting 2024-06-03 10:17
Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer and Gastric Cancer 2024-06-03 09:35
Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging 2024-06-03 09:08
Innovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting 2024-06-02 13:19
1 30 31 32 33 34 451